source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[biological replicate]	characteristics[phenotype]	assay name	technology type	comment[data file]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[fractionation method]	comment[file uri]
Sample 1	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 1	proteomic profiling by mass spectrometry	BreastCancerMem_Fr1.raw	1	1	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw
Sample 1	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 1	proteomic profiling by mass spectrometry	BreastCancerMem_Fr1.raw	1	1	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw
Sample 2	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 2	proteomic profiling by mass spectrometry	BreastCancerMem_Fr2.raw	1	2	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw
Sample 2	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 2	proteomic profiling by mass spectrometry	BreastCancerMem_Fr2.raw	1	2	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw
Sample 3	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 3	proteomic profiling by mass spectrometry	BreastCancerMem_Fr3.raw	1	3	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw
Sample 3	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 3	proteomic profiling by mass spectrometry	BreastCancerMem_Fr3.raw	1	3	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw
Sample 4	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 4	proteomic profiling by mass spectrometry	BreastCancerMem_Fr4.raw	1	4	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw
Sample 4	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 4	proteomic profiling by mass spectrometry	BreastCancerMem_Fr4.raw	1	4	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw
Sample 5	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 5	proteomic profiling by mass spectrometry	BreastCancerMem_Fr5.raw	1	5	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw
Sample 5	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 5	proteomic profiling by mass spectrometry	BreastCancerMem_Fr5.raw	1	5	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw
Sample 6	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 6	proteomic profiling by mass spectrometry	BreastCancerMem_Fr6.raw	1	6	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw
Sample 6	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 6	proteomic profiling by mass spectrometry	BreastCancerMem_Fr6.raw	1	6	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw
Sample 7	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 7	proteomic profiling by mass spectrometry	BreastCancerMem_Fr7.raw	1	7	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw
Sample 7	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 7	proteomic profiling by mass spectrometry	BreastCancerMem_Fr7.raw	1	7	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw
Sample 8	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 8	proteomic profiling by mass spectrometry	BreastCancerMem_Fr8.raw	1	8	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw
Sample 8	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 8	proteomic profiling by mass spectrometry	BreastCancerMem_Fr8.raw	1	8	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw
Sample 9	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 9	proteomic profiling by mass spectrometry	BreastCancerMem_Fr9.raw	1	9	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw
Sample 9	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 9	proteomic profiling by mass spectrometry	BreastCancerMem_Fr9.raw	1	9	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw
Sample 10	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 10	proteomic profiling by mass spectrometry	BreastCancerMem_Fr10.raw	1	10	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw
Sample 10	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 10	proteomic profiling by mass spectrometry	BreastCancerMem_Fr10.raw	1	10	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw
Sample 11	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 11	proteomic profiling by mass spectrometry	BreastCancerMem_Fr11.raw	1	11	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw
Sample 11	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 11	proteomic profiling by mass spectrometry	BreastCancerMem_Fr11.raw	1	11	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw
Sample 12	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 12	proteomic profiling by mass spectrometry	BreastCancerMem_Fr12.raw	1	12	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw
Sample 12	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 12	proteomic profiling by mass spectrometry	BreastCancerMem_Fr12.raw	1	12	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw
Sample 13	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 13	proteomic profiling by mass spectrometry	BreastCancerMem_Fr13.raw	1	13	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw
Sample 13	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 13	proteomic profiling by mass spectrometry	BreastCancerMem_Fr13.raw	1	13	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw
Sample 14	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 14	proteomic profiling by mass spectrometry	BreastCancerMem_Fr14.raw	1	14	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw
Sample 14	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 14	proteomic profiling by mass spectrometry	BreastCancerMem_Fr14.raw	1	14	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw
Sample 15	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 15	proteomic profiling by mass spectrometry	BreastCancerMem_Fr15.raw	1	15	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw
Sample 15	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 15	proteomic profiling by mass spectrometry	BreastCancerMem_Fr15.raw	1	15	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw
Sample 16	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 16	proteomic profiling by mass spectrometry	BreastCancerMem_Fr16.raw	1	16	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw
Sample 16	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 16	proteomic profiling by mass spectrometry	BreastCancerMem_Fr16.raw	1	16	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw
Sample 17	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 17	proteomic profiling by mass spectrometry	BreastCancerMem_Fr17.raw	1	17	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw
Sample 17	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 17	proteomic profiling by mass spectrometry	BreastCancerMem_Fr17.raw	1	17	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw
Sample 18	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 18	proteomic profiling by mass spectrometry	BreastCancerMem_Fr18.raw	1	18	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw
Sample 18	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 18	proteomic profiling by mass spectrometry	BreastCancerMem_Fr18.raw	1	18	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw
Sample 19	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 19	proteomic profiling by mass spectrometry	BreastCancerMem_Fr19.raw	1	19	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw
Sample 19	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 19	proteomic profiling by mass spectrometry	BreastCancerMem_Fr19.raw	1	19	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw
Sample 20	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 20	proteomic profiling by mass spectrometry	BreastCancerMem_Fr20.raw	1	20	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw
Sample 20	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 20	proteomic profiling by mass spectrometry	BreastCancerMem_Fr20.raw	1	20	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw
Sample 21	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 21	proteomic profiling by mass spectrometry	BreastCancerMem_Fr21.raw	1	21	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw
Sample 21	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 21	proteomic profiling by mass spectrometry	BreastCancerMem_Fr21.raw	1	21	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw
Sample 22	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 22	proteomic profiling by mass spectrometry	BreastCancerMem_Fr22.raw	1	22	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw
Sample 22	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 22	proteomic profiling by mass spectrometry	BreastCancerMem_Fr22.raw	1	22	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw
Sample 23	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 23	proteomic profiling by mass spectrometry	BreastCancerMem_Fr23.raw	1	23	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw
Sample 23	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 23	proteomic profiling by mass spectrometry	BreastCancerMem_Fr23.raw	1	23	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw
Sample 24	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 24	proteomic profiling by mass spectrometry	BreastCancerMem_Fr24.raw	1	24	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw
Sample 24	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 24	proteomic profiling by mass spectrometry	BreastCancerMem_Fr24.raw	1	24	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw
Sample 25	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 25	proteomic profiling by mass spectrometry	BreastCancerMem_Fr25.raw	1	25	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw
Sample 25	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 25	proteomic profiling by mass spectrometry	BreastCancerMem_Fr25.raw	1	25	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw
Sample 26	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 26	proteomic profiling by mass spectrometry	BreastCancerMem_Fr26.raw	1	26	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw
Sample 26	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 26	proteomic profiling by mass spectrometry	BreastCancerMem_Fr26.raw	1	26	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw
Sample 27	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 27	proteomic profiling by mass spectrometry	BreastCancerMem_Fr27.raw	1	27	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw
Sample 27	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 27	proteomic profiling by mass spectrometry	BreastCancerMem_Fr27.raw	1	27	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw
Sample 28	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 28	proteomic profiling by mass spectrometry	BreastCancerMem_Fr28.raw	1	28	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw
Sample 28	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 28	proteomic profiling by mass spectrometry	BreastCancerMem_Fr28.raw	1	28	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw
Sample 29	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 29	proteomic profiling by mass spectrometry	BreastCancerMem_Fr29.raw	1	29	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw
Sample 29	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 29	proteomic profiling by mass spectrometry	BreastCancerMem_Fr29.raw	1	29	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw
Sample 30	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 30	proteomic profiling by mass spectrometry	BreastCancerMem_Fr30.raw	1	30	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw
Sample 30	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 30	proteomic profiling by mass spectrometry	BreastCancerMem_Fr30.raw	1	30	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw
Sample 31	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 31	proteomic profiling by mass spectrometry	BreastCancerMem_Fr31.raw	1	31	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw
Sample 31	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 31	proteomic profiling by mass spectrometry	BreastCancerMem_Fr31.raw	1	31	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw
Sample 32	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 32	proteomic profiling by mass spectrometry	BreastCancerMem_Fr32.raw	1	32	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw
Sample 32	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 32	proteomic profiling by mass spectrometry	BreastCancerMem_Fr32.raw	1	32	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw
Sample 33	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 33	proteomic profiling by mass spectrometry	BreastCancerMem_Fr33.raw	1	33	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw
Sample 33	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 33	proteomic profiling by mass spectrometry	BreastCancerMem_Fr33.raw	1	33	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw
Sample 34	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 34	proteomic profiling by mass spectrometry	BreastCancerMem_Fr34.raw	1	34	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw
Sample 34	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 34	proteomic profiling by mass spectrometry	BreastCancerMem_Fr34.raw	1	34	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw
Sample 35	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 35	proteomic profiling by mass spectrometry	BreastCancerMem_Fr35.raw	1	35	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw
Sample 35	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 35	proteomic profiling by mass spectrometry	BreastCancerMem_Fr35.raw	1	35	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw
Sample 36	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with high-risk MammaPrint breast cancer	run 36	proteomic profiling by mass spectrometry	BreastCancerMem_Fr36.raw	1	36	AC=MS:1002624;NT=iTRAQ reagent 114	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw
Sample 36	Homo sapiens	Breast	not available	not available	not available	not available	Breast cancer	not available	1	18 patients with with low-risk MammaPrint breast cancer	run 36	proteomic profiling by mass spectrometry	BreastCancerMem_Fr36.raw	1	36	AC=MS:1002625;NT=iTRAQ reagent 115	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Lys-C;AC=MS:1001309	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144	NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144	NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw
